CXCR3 and acute lymphoblastic leukemia: Accordingly, targeting NOTCH1 signaling with DBZ, a γ-secretase inhibitor, reduced CXCR3 mRNA and protein levels in both human and murine T-ALL cells (Supplemental Figure 1, E–H).